A voyage through history
“Lines Drawn across the Globe,” a new book by MIT Professor Mary Fuller, looks at the worldwide vision of English exploration proponent Richard Hakluyt.
“Lines Drawn across the Globe,” a new book by MIT Professor Mary Fuller, looks at the worldwide vision of English exploration proponent Richard Hakluyt.
Assistant Professor Cathy Wu is addressing traffic control problems by leveraging deep reinforcement learning.
A Lincoln Laboratory team visited Hill Air Force Base in Utah to determine how susceptible the latest-generation mobile network is to detection, geolocation, and jamming.
Professor of physics will use US Department of Defense fellowship to study quantum science with ultracold atoms.
Predictions from the OncoNPC model could enable doctors to choose targeted treatments for difficult-to-treat tumors.
An experiment in Egypt suggests ways to spread information for women facing domestic violence.
MIT professor discusses the US surgeon general’s recent advisory and why scrolling social media can lead to depression and anxiety.
In addition to turning on genes involved in cell defense, the STING protein also acts as an ion channel, allowing it to control a wide variety of immune responses.
SMART researchers find the enzyme RlmN, which directly senses chemical and environmental stresses, can be targeted in drug development.
By fine-tuning the spin density in some materials, researchers may be able to develop new quantum sensors or quantum simulations.
With a new, user-friendly interface, researchers can quickly design many cellular metamaterial structures that have unique mechanical properties.
Made of cement, carbon black, and water, the device could provide cheap and scalable energy storage for renewable energy sources.
“PhotoGuard,” developed by MIT CSAIL researchers, prevents unauthorized image manipulation, safeguarding authenticity in the era of advanced generative models.
The new device, which can be incorporated into a bra, could allow more frequent monitoring of patients at high risk for breast cancer.
MIT researchers find timing and dosage of DNA-damaging drugs are key to whether a cancer cell dies or enters senescence.